title: [Affective disorders and diabetes].
abstract: Affective disorders increase the risk for the occurrence of type 2 diabetes, and the presence of type 1 or type 2 diabetes may contribute to the development of an affective disorder. Certain antidepressants and behavioral therapy seem to improve blood sugar levels in patients suffering from depression and type 2 diabetes, although these antidepressants may lead to weight gain. However, some antipsychotics unfavorably affect weight development and carbohydrate metabolism. In diabetic patients, the physician should be particularly alert to affective symptoms, and in mentally ill patients, he should look out for metabolic changes that may be caused by diabetogenic psychopharmacological medication.
authors.affiliation: Max-PlanckInstitut für Psychiatrie, München. himmerich@mpipsykl.mpg.de
authors.forename: H
authors.initials: H
authors.lastname: Himmerich
authors.forename: T
authors.initials: T
authors.lastname: Pollmächer
authors.forename: L
authors.initials: L
authors.lastname: Schaaf
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D015928:Cognitive Behavioral Therapy; D003863:Depression / Q000097:blood / Q000150:complications / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005951:Glucose Tolerance Test; D006801:Humans; D015201:Meta-Analysis as Topic; D019964:Mood Disorders / Q000097:blood / Q000150:complications* / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D015430:Weight Gain
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001786:Blood Glucose